Zoladex 3,6 mg implantat
| Name | Zoladex 3,6 mg implantat |
|---|---|
| Marketing Authorisation Number | HR-H-247320153 |
| Active Substance | goserelinacetat |
| Composition | implantat u napunjenoj štrcaljki sadrži 3,6 mg goserelina u obliku goserelinacetata dispergiranog u biološki razgradivom matriksu kopolimera |
| Pharmaceutical Form | implantat |
| Manufacturer | AstraZeneca AB, Sodertalje, Švedska |
| Marketing Authorisation Holder | AstraZeneca d.o.o., Ulica Vjekoslava Heinzela 70, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.11.2015 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/14-02/265 |
| Registration Number | 381-12-01/30-15-15 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L02AE03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
